A non-invasive, objective means of assessing the effects of medical treatment would be invaluable for the management of patients with ischaemic heart disease, providing an important adjunct to symptomatic relief in determining the adequacy of treatment. Though exercise testing and measurements of exercise tolerance have proved useful, the subjective aspects involved in training and in pain assessment limit the usefulness of these techniques.' Few will deny the value of beta-blockade in controlling angina yet studies reporting the effects of propranolol on exercise-induced ST 
A non-invasive, objective means of assessing the effects of medical treatment would be invaluable for the management of patients with ischaemic heart disease, providing an important adjunct to symptomatic relief in determining the adequacy of treatment. Though exercise testing and measurements of exercise tolerance have proved useful, the subjective aspects involved in training and in pain assessment limit the usefulness of these techniques.' Few will deny the value of beta-blockade in controlling angina yet studies reporting the effects of propranolol on exercise-induced ST segment depression have been conflicting.2-4 This must, in part, be related to the lack of quantitative data when measurements of the depth of ST depression are made at only one or, at best, six praecordial sites. The introduction of praecordial surface mapping after exercise adds an extra dimension to the standard lead systems since both the area and severity of ST segment changes that are projected on to the front of the chest can be measured.5 The present study was designed, therefore, to determine the effects of established long-term beta-blockade on the praecordial projection of ST segment changes and to illustrate the value of this noninvasive objective technique in evaluating drug treatment in each individual patient. * This work was supported by a grant from the British Heart Foundation.
Received for publication 31 May 1979 Methods Fifty-two patients (38 men, 14 women) with frequent incapacitating angina pectoris were studied. All reported daily episodes of chest pain and all developed ST segment depression after exercise. The mean age was 57 years. Before starting medical treatment, a 16 point praecordial electrocardiogram was recorded before and after exercise using a directwriting ink jet Mingograf (Elema Schonander) recording on four channels simultaneously.f The 16 electrodes were connected to the electrocardiograph using a four-way switch. All patients developed chest pain during the exercise test, and this was used as the indication to stop the test.
The as outpatients and were seen at least every two weeks. Propranolol was started at a dose of 10 mg three times daily and increased according to patient tolerance, symptomatic relief, and serial heart rate and blood pressure recordings. The mean final dose used was 300 mg daily in divided doses (range 120 to 480 mg) and compliance with therapy was assessed by questioning and by noting an adequate bradycardia at rest. When the optimal dose of propranolol in terms of symptomatic relief, heart rate response (less than 65/min), and drug tolerance had been achieved for each patient for at least two weeks, the praecordial electrocardiogram was repeated before and after exercise using the same procedure and workload as at the first test. Patients not suitable for treatment with propranolol, or unable to tolerate the drug, or considered not to be taking it properly were excluded from the study before the second test and are not part of these data.
A further 20 patients receiving no drug treatment were studied to determine the reproducibility of the praecordial area and severity of the ST segment depression. Exercise tests using the above procedure were repeated on separate days two months apart and the praecordial electrocardiogram was recorded before and after exercise. The same workload was used in both tests.
The criteria of the Scandinavian Committee on ECG Classification8 were used to interpret the electrocardiograms. ST segment changes were read with reference to the PQ segment and depression was considered to be present if there was 1 mm or more of shift lasting for 0-08 second or longer. Contour maps of the area of ST segment change were drawn9; the total area being defined as the number of praecordial positions showing a significant ST segment alteration, and severity of EST as the total ST segment shift in millimetres for all the 16 positions.
Results
The mean resting and peak exercise heart rates (±1 standard deviation) were, respectively, 74±8 and 138 ± 14 beats a minute before starting propranolol, and 56 ±5 and 92 ±6 beats a minute with treatment. The mean blood pressure before and after propranolol was 137/7 i and 117/68 mmHg, respectively. All patients were able to achieve the same workload after treatment as at the beginning of the study Fig. 1 (a Of these 20 patients, 12 were free from pain on exercise when on propranolol; one was now free from symptoms at any time, six had only occasional chest pain, and 13 still had frequent episodes of angina. The single chest lead showed complete resolution of ST segment changes in four patients (mean ST segment depression before and after treatment 1-7 and 1-2 mm, respectively). Fig. 4 shows the sequence of contour maps from a typical patient in this group. On propranolol this patient now had infrequent angina and was free of pain when exercised.
REPRODUCIBILITY
The mean praecordial area and severity of ST segment depression found at the first and second exercise tests in the 20 patients in whom reproducibility studies were performed are shown in Fig. 5a and 5b. The discrepancies between previous reports on the effects of beta-blockers in angina become clear when the use of the single chest lead (V5) is compared with praecordial surface mapping in our patients. In 12 of them when on propranolol, reliance on V5 alone would have failed to identify exercise-induced ST segment depression that was present in other areas of the praecordium. Given the inconstant relation between the heart and the front of the chest with alterations in position, respiration, and heart rate, this is not surprising, and no single fixed position lead can be considered a reliable indicator of ST segment change.
The relations between symptomatic relief, exercise-induced chest pain, and the praecordial electrocardiographic signs of ischaemia after propranolol are of particular interest. 
